艾美捷抗人干扰素α单抗MT2 相关说明书

干扰素-alpha（IFN-alpha）是I型干扰素，存在13种亚型：IFN-alpha1，2，4，5，6，7与其他亚型一样，干扰素-alpha2（IFN-alpha2）主要由病毒产生。在感知到病毒DNA或RNA等危险信号的存在后感染细胞。因此IFN-alpha2与其受体的结合引发抗病毒反应，但也显示出抗肿瘤作用。作为个被发现，IFN-alpha2是研究J为广泛的亚型，它已被用作细胞因子治疗与丙型肝炎病毒感染。

艾美捷抗人干扰素α单抗MT2基本参数：

英文名称：Anti-human IFN-alpha mAb (MT2), biotin

编号：3423-6-1000

规格：1mg

应用类型：ELISpot, ELISA

免疫原：天然和重组人IFN-a亚型2a, 2b, 2c

来源宿主：小鼠

反应性：人

保存建议：建议2-8°C保存，有效期为18个月。

艾美捷抗人干扰素α单抗MT2参考文献：

Bijak, M., et al. (2017). Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets ａnd Leukocytes. Nutrients.

Chan, L. J., et al. (2017). An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure ａnd Antiviral Activity of Interferon after Subcutaneous Administration. Biomacromolecules.

Hochmann, S., et al. (2018). Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer. Sci Rep.

Ingelsson, B., et al. (2018). Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG ａnd non-CpG oligodeoxynucleotides of class C. Proceedings of the National Academy of Sciences of the United States of America.

Yadav, P., et al. (2018). Distribution of therapeutic proteins into thoracic lymph after intravenous administration is protein size-dependent ａnd primarily occurs within the liver ａnd mesentery. J Control Release.

来源：https://www.amyjet.com/products/3423-6-1000.shtml